Package 25021-229-05

Brand: cytarabine

Generic: cytarabine
NDC Package

Package Facts

Identity

Package NDC 25021-229-05
Digits Only 2502122905
Product NDC 25021-229
Product ID 25021-229_e9aed280-7c58-4817-b54d-ccbbdd4af575
Description

5 VIAL in 1 CARTON (25021-229-05) / 5 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2023-06-01
Brand cytarabine
Generic cytarabine
Sample Package No

Linked Drug Pages (1)

cytarabine ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRATHECAL", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "e9aed280-7c58-4817-b54d-ccbbdd4af575", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["04079A1RDZ"], "rxcui": ["1731355"], "spl_set_id": ["90f5c7ab-9f15-487d-ba69-ee4107434bcc"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 VIAL in 1 CARTON (25021-229-05)  / 5 mL in 1 VIAL", "package_ndc": "25021-229-05", "marketing_start_date": "20230601"}], "brand_name": "cytarabine", "product_id": "25021-229_e9aed280-7c58-4817-b54d-ccbbdd4af575", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "25021-229", "generic_name": "cytarabine", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cytarabine", "active_ingredients": [{"name": "CYTARABINE", "strength": "20 mg/mL"}], "application_number": "ANDA211937", "marketing_category": "ANDA", "marketing_start_date": "20230601", "listing_expiration_date": "20261231"}